A Phase IV Study to Evaluate the Efficacy, Safety and Tolerability of Tenofovir DF in Asian-American Adults With Chronic Hepatitis B Infection.
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2011
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 02 Aug 2011 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2009 Planned end date changed from 1 Dec 2010 to 1 Jan 2010 as reported by ClinicalTrials.gov.